| Literature DB >> 17885444 |
Abstract
KEY POINTS: (1) A large number of treatment options have shown generally moderate efficacy in the treatment of diabetic painful neuropathy.(2) Tricyclic antidepressants are the mainstay of therapy, with anticonvulsants, opioids and serotonin-noradrenaline reuptake inhibitors also having a place.(3) Head-to-head trials of current treatments are needed. Meanwhile, selection of therapeutic agents should be individualised.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17885444 DOI： 10.1097/WCO.0b013e32828da14e
Source DB: PubMed Journal: Curr Opin Neurol ISSN： 1350-7540 Impact factor: 5.710